Insights into the Structure and Pharmacology of the Human Trace Amine-Associated Receptor 1 (hTAAR1): Homology Modelling and Docking Studies

Chemical Biology and Drug Design

Volumn 81, Issue 4, 2013, Pages 509-516

  Cichero, Elena ^a   Espinoza, Stefano ^b   Gainetdinov, Raul R ^b   Brasili, Livio ^c   Fossa, Paola ^a  

^a UNIVERSITY OF GENOA   (Italy)

^b ISTITUTO ITALIANO DI TECNOLOGIA   (Italy)

^c UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

Author keywords

GPCR; Homology modelling; Molecular docking; TAAR1; Trace amine associated receptor

Indexed keywords

AGENTS INTERACTING WITH TRANSMITTER, HORMONE OR DRUG RECEPTORS; AMINE; BETA 2 ADRENERGIC RECEPTOR; G PROTEIN COUPLED RECEPTOR; PHENETHYLAMINE; PROTEIN HUMAN TRACE AMINE ASSOCIATED RECEPTOR 1; RO 516607; SEROTONIN 1A RECEPTOR; TYRAMINE, 3 IODOTHYRONAMINE; UNCLASSIFIED DRUG;

ARTICLE; BINDING SITE; COMPUTER MODEL; CRYSTALLIZATION; HUMAN; MOLECULAR DOCKING; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN STRUCTURE; X RAY ANALYSIS;

AMINO ACID SEQUENCE; BINDING SITES; HUMANS; MOLECULAR DOCKING SIMULATION; MOLECULAR SEQUENCE DATA; OXAZOLES; PHENETHYLAMINES; PROTEIN STRUCTURE, TERTIARY; RECEPTOR, SEROTONIN, 5-HT1A; RECEPTORS, G-PROTEIN-COUPLED; SEQUENCE ALIGNMENT; THYRONINES;

EID: 84875644288     PISSN: 17470277     EISSN: 17470285     Source Type: Journal    
DOI: 10.1111/cbdd.12018     Document Type: Article

References (30)

1. Berry M.D. (2004) Mammalian central nervous system trace amines. Pharmacologic amphetamines, physiologic neuromodulators. J Neurochem;90:257-271.
2. Borowsky B., Adham N., Jones K.A., Raddatz R., Artymyshyn R., Ogozalek K.L., Durkin M.M. et al. (2001) Trace amines: identification of a family of mammalian G protein-coupled receptors. Proc Natl Acad Sci U S A;98:8966-8971.
3. Bunzow J.R., Sonders M.S., Arttamangkul S., Harrison L.M., Zhang G., Quigley D.I., Darland T., Suchland K.L., Pasumamula S., Kennedy J.L., Olson S.B., Magenis R.E., Amara S.G., Grandy D.K. (2001) Amphetamine, 3, 4-methylenedioxymethamphetamine, lysergic acid diethylamide, and metabolites of the catecholamine neurotransmitters are agonists of a rat trace amine receptor. Mol Pharmacol;60:1181-1188.
4. Lindemann L., Hoener M.C. (2005) A renaissance in trace amines inspired by a novel GPCR family. Trends Pharmacol Sci;26:274-281.
5. Barak L.S., Salahpour A., Zhang X., Masri B., Sotnikova T.D., Ramsey A.J., Violin J.D., Lefkowitz R.J., Caron M.G., Gainetdinov R.R. (2008) Pharmacological characterization of membrane-expressed human trace amine-associated receptor 1 (TAAR1) by a bioluminescence resonance energy transfer cAMP biosensor. Mol Pharmacol;74:585-594.
6. Zucchi R., Chiellini G., Scanlan T.S., Grandy D.K. (2006) Trace amine-associated receptors and their ligands. Br J Pharmacol;149:967-978.
7. Scanlan T.S., Suchland K.L., Hart M.E., Chiellini G., Huang Y., Kruzich P.J., Frascarelli S., Crossley D.A., Bunzow J.R., Ronca-Testoni S., Lin E.T., Hatton D., Zucchi R., Grandy D.K. (2004) 3-Iodothyronamine is an endogenous and rapid-acting derivative of thyroid hormone. Nat Med;10:638-642.
8. Grandy D.K. (2007) Trace amine-associated receptor 1-Family archetype or iconoclast?Pharmacol Ther;116:355-390.
9. Sotnikova T.D., Beaulieu J.M., Espinoza S., Masri B., Zhang X., Salahpour A., Barak L.S., Caron M.G., Gainetdinov R.R. (2010) The dopamine metabolite 3-methoxytyramine is a neuromodulator. PLoS One;5:e13452.
10. Lewin A.H., Navarro H.A., Mascarella S.W. (2008) Structure-activity correlations for beta-phenethylamines at human trace amine receptor 1. Bioorg Med Chem;16:7415-7423.
11. Tan E.S., Groban E.S., Jacobson M.P., Scanlan T.S. (2008) Toward deciphering the code to aminergic G protein-coupled receptor drug design. Chem Biol;15:343-353.
12. Bradaia A., Trube G., Stalder H., Norcross R.D., Ozmen L., Wettstein J.G., Pinard A., Buchy D., Gassmann M., Hoener M.C., Bettler B. (2009) The selective antagonist EPPTB reveals TAAR1-mediated regulatory mechanisms in dopaminergic neurons of the mesolimbic system. Proc Natl Acad Sci U S A;106:20081-20086.
13. Revel F.G., Moreau J.L., Gainetdinov R.R., Bradaia A., Sotnikova T.D., Mory R., Durkin S. et al. (2011) TAAR1 activation modulates monoaminergic neurotransmission, preventing hyperdopaminergic and hypoglutamatergic activity. Proc Natl Acad Sci U S A;108:8485-8490.
14. Xie Z., Westmoreland S.V., Bahn M.E., Chen G.L., Yang H., Vallender E.J., Yao W.D., Madras B.K., Miller G.M. (2007) Rhesus monkey trace amine-associated receptor 1 signaling: enhancement by monoamine transporters and attenuation by the D2 autoreceptor in vitro. J Pharmacol Exp Ther;321:116-127.
15. Xie Z., Westmoreland S.V., Miller G.M. (2008) Modulation of monoamine transporters by common biogenic amines via trace amine-associated receptor 1 and monoamine autoreceptors in human embryonic kidney 293 cells and brain synaptosomes. J Pharmacol Exp Ther;325:629-640.
16. Espinoza S., Salahpour A., Masri B., Sotnikova T.D., Messa M., Barak L.S., Caron M.G., Gainetdinov R.R. (2011) Functional interaction between trace amine-associated receptor 1 and dopamine D2 receptor. Mol Pharmacol;80:416-425.
17. Lindemann L., Meyer C.A., Jeanneau K., Bradaia A., Ozmen L., Bluethmann H., Bettler B., Wettstein J.G., Borroni E., Moreau J.L., Hoener M.C. (2008) Trace amine-associated receptor 1 modulates dopaminergic activity. J Pharmacol Exp Ther;324:948-956.
18. Sotnikova T.D., Caron M.G., Gainetdinov R.R. (2009) Trace amine-associated receptors as emerging therapeutic targets. Mol Pharmacol;76:229-235.
19. Sotnikova D.T., Olesya I.Z., Ghisi V., Caron M.G., Gainetdinov R.R. (2008) Trace amine associated receptor 1 and movement control. Parkinsonism Relat Disord;14:S99-S102.
20. Rosenbaum D.M., Zhang C., Lyons J.A., Holl R., Aragao D., Arlow D.H., Rasmussen S.G. et al. (2011) Structure and function of an irreversible agonist-β(2) adrenoceptor complex. Nature;469:236-240.
21. Franchini S., Prandi A., Baraldi A., Sorbi C., Tait A., Buccioni M., Marucci G., Cilia A., Pirona L., Fossa P., Cichero E., Brasili L. (2010) 1, 3-Dioxolane-based ligands incorporating a lactam or imide moiety: structure-affinity/activity relationship at alpha1-adrenoceptor subtypes and at 5-HT1A receptors. Eur J Med Chem;45:3740-3751.
22. 1A receptors. J Med Chem;55:23-36.
23. Bairoch A., Apweiler R. (2000) The SWISS-PROT protein sequence database and its supplement TrEMBL in 2000. Nucleic Acids Res;28:45-48.
24. Berman H.M., Westbrook J., Feng Z., Gilliland G., Beth T.N., Weissig H., Shindyalov I.N., Bourne P.E. (2000) The protein data bank. Nucleic Acids Res;28:235-242.
25. Levitt M. (1992) Accurate modeling of protein conformation by automatic segment matching. J Mol Biol;226:507-533.
26. Fechteler T., Dengler U., Schomberg D. (1995) Prediction of protein three-dimensional structures in insertion and deletion regions: a procedure for searching data bases of representative protein fragments using geometric scoring criteria. J Mol Biol;253:114-131.
27. Cornell W.D.C.P., Bayly C.I., Gould I.R., Merz K.M., Ferguson D.M., Spellmeyer D.C., Fox T., Caldwell J.W., Kollman P.A.J. (1995) A second generation force field for the simulation of proteins, nucleic acids and organic molecules. Am Chem Soc;117:5179-5196.
28. Zhang C., Vasmatizis G., Cornette J.L., DeLisi C. (1997) Determination of atomic desolvation energies from the structures of crystallized proteins. J Mol Biol;267:707-726.
29. Dunbrack R.L., Bayesian F.E. (1997) Statistical analysis of protein sidechain rotamer preferences. Protein Sci;6:1661-1681.
30. 1A receptor using automated docking of bioactive compounds with defined geometry. J Med Chem;49:205-214.